FIELD : biotechnology.SUBSTANCE : present invention relates to the field of biotechnology, specifically to a new insulin agonist conjugated with incretin protein, and can be used in medicine.EFFECT : conjugate of insulin and incretin of the present invention has agonist activity both on the insulin receptor and on the corresponding incretin receptor, and can be used for the treatment of juvenile diabetes and adult diabetes at a later stage.8 cl, 15 dwg, 5 tbl, 9 ex